Publications by authors named "Lizbeth Gallagher"

Claim this Profile
D
Design and synthesis of a novel series of (1'S,2R,4'S)-3H-4'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2'-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor.
James Cook, F Christopher Zusi, Matthew D Hill, Haiquan Fang, Bradley Pearce, Lizbeth Gallagher

Bioorg Med Chem Lett· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.
Linda J Bristow, Amy E Easton, Yu-Wen Li, Digavalli V Sivarao, Regina Lidge, Lizbeth Gallagher

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.
Christiana Iwuagwu, Dalton King, Ivar M McDonald, James Cook, F Christopher Zusi, Lizbeth Gallagher

Bioorg Med Chem Lett· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.
Dalton King, Christiana Iwuagwu, Jim Cook, Ivar M McDonald, Robert Mate, Lizbeth Gallagher

ACS Med Chem Lett· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.
Matthew D Hill, Haiquan Fang, Sivarao V Digavalli, Francine L Healy, Lizbeth Gallagher

Bioorg Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.
James Cook, F Christopher Zusi, Ivar M McDonald, Dalton King, Matthew D Hill, Lizbeth Gallagher

J Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of 1-Pyrazolo[3,4-]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.
Matthew D Hill, Haiquan Fang, Jeffrey M Brown, Thaddeus Molski, Amy Easton, Lizbeth Gallagher

ACS Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a high-throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay.
Andrew D Wagner, Lisa Elkin, Kathy Mosure, Lizbeth Gallagher, Lindsey K Stavola

Rapid Commun Mass Spectrom· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy.
Yu-Wen Li, Matthew A Seager, Trevor Wojcik, Karen Heman, Thaddeus F Molski, Lizbeth Gallagher

Neuropharmacology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an LC-MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays.
Marianne Vath, Lizbeth Gallagher, Wilson Shou, Harold Weller, Lisa Elkin

J Chromatogr B Analyt Technol Biomed Life Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists.
Ivar M McDonald, Robert A Mate, F Christopher Zusi, Hong Huang, Debra J Post-Munson, Lizbeth Gallagher

Bioorg Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis